. Infection of cats with the feline immunodeficiency virus (FIV) produces an immunodeficiency syndrome with pathogenesis very similar to that observed in HIV. FIV shares several genetic similarities with HIV and therefore provides an animal model for evaluating viral determinants of pathogenesis. Critical for the design of an efficacious lentivirus vaccine is the identification of viral antigens that are essential for inducing protective immune responses; at the same time it is necessary to elucidate and eliminate viral functions that may lead to immune systems dyregulation. The proposed experiments are based on the hypothesis that infection of cats with mutant FIV clones by proviral DNA injections will be a means to achieve protective immunity.
Three specific aims are proposed:
Specific Aim 1 : To evaluate viral replication, distribution and immunopathological abnormalities during the primary stage and later stages of infection in specific tissue and cell populations harvested from cats infected with infectious FIV mutant viruses delivered by intramuscular injection of proviral DNA.
Specific Aim 2 : To analyze virus specific cytotoxic T-cell responses, neutralizing antibody avidity in cats inoculated with infectious mutant proviral DNA.
Specific Aim 3 : To test for protective immunity in cats inoculated with infectious mutant proviral DNA by challenging with pathogenic biological isolates of FIV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI040896-02
Application #
2672932
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Project Start
1997-06-01
Project End
2001-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California Davis
Department
Internal Medicine/Medicine
Type
Schools of Veterinary Medicine
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Maksaereekul, Saipiroon; Dubie, Robert A; Shen, Xiaoying et al. (2009) Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV. Vaccine 27:3754-65
Shen, Xiaoying; Leutenegger, Christian M; Stefano Cole, Kelly et al. (2007) A feline immunodeficiency virus vif-deletion mutant remains attenuated upon infection of newborn kittens. J Gen Virol 88:2793-9
Gupta, Soumi; Leutenegger, Christian M; Dean, Gregg A et al. (2007) Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon. J Virol 81:465-73
Gupta, Soumi; Leutenegger, Christian; Dean, Gregg et al. (2006) Construction and characterization of feline immunodeficiency virus proviral mutants that coexpress interferon gamma and green fluorescent protein. AIDS Res Hum Retroviruses 22:342-9
Gemeniano, Malou C; Sawai, Earl T; Sparger, Ellen E (2004) Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest. Virology 325:167-74
Gemeniano, Malou C; Sawai, Earl T; Leutenegger, Christian M et al. (2003) Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity. J Virol 77:8819-30
Lockridge, K M; Chien, M; Dean, G A et al. (2000) Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA. Virology 273:67-79